GSCM
RMD icon

Greenfield Seitz Capital Management’s ResMed RMD Stock Holding History

Greenfield Seitz Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.53M Sell
48,912
-199
-0.4% -$41.2K 2.84% 8
2026
Q1 		$11M Buy
49,111
+235
+0.5% +$58.6K 3.33% 6
2025
Q4 		$11.8M Sell
48,876
-477
-1% -$122K 3.86% 4
2025
Q3 		$13.5M Sell
49,353
-2,106
-4% -$575K 4.35% 4
2025
Q2 		$13.3M Sell
51,459
-389
-0.8% -$92.8K 4.69% 2
2025
Q1 		$11.6M Sell
51,848
-635
-1% -$148K 4.43% 2
2024
Q4 		$12M Sell
52,483
-1,042
-2% -$251K 4.57% 2
2024
Q3 		$13.1M Sell
53,525
-1,916
-3% -$428K 4.79% 2
2024
Q2 		$10.6M Sell
55,441
-763
-1% -$155K 3.93% 2
2024
Q1 		$11.1M Sell
56,204
-2,874
-5% -$527K 4.15% 2
2023
Q4 		$10.2M Buy
+59,078
New +$9.08M 4.05% 2

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Greenfield Seitz Capital Management's RMD Position: Q2 2026 in Review

Greenfield Seitz Capital Management reduced its ResMed (RMD) stake by 0.41% in Q2 2026, selling an estimated $41.2K and leaving 48,912 shares worth $9.53M. The position accounts for 2.84% of the portfolio, ranked #8.

Greenfield Seitz Capital Management first reported a position in RMD in Q4 2023 and has held it in 11 quarters since. The position peaked at $13.5M in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Greenfield Seitz Capital Management held 48,912 shares of ResMed worth $9.53M as of Q2 2026.
  • Greenfield Seitz Capital Management sold 199 ResMed shares in Q2 2026, an estimated $41.2K.
  • ResMed made up 2.84% of Greenfield Seitz Capital Management's portfolio in Q2 2026, its #8 holding.
  • Greenfield Seitz Capital Management first reported a position in ResMed in Q4 2023 and has held it in 11 quarters since.
  • Greenfield Seitz Capital Management's ResMed position peaked at $13.5M in Q3 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Greenfield Seitz Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.